Author Behrens, Georg M. N.

• 2019 | Journal Article | Research Paper | 
  ​ ​Pediatric Healthcare Utilization in a Large Cohort of Refugee Children Entering Western Europe During the Migrant Crisis​
  Happle, C.; Dopfer, C.; Ernst, D. ; Kleinert, E. ; Vakilzadeh, A.; Hellms, S. & Evlampidou, I. et al.​ (2019) 
  International Journal of Environmental Research and Public Health, 16(22) pp. 4415​.​ DOI: https://doi.org/10.3390/ijerph16224415 
  ​Details  DOI 

• 2020 | Journal Article | 
  ​ ​Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods​
  Bošnjak, B.; Stein, S. C.; Willenzon, S.; Cordes, A. K.; Puppe, W.; Bernhardt, G. & Ravens, I. et al.​ (2020) 
  Cellular & Molecular Immunology, 18(4) pp. 936​-944​.​ DOI: https://doi.org/10.1038/s41423-020-00573-9 
  ​Details  DOI 

• 2021 | Journal Article | 
  ​ ​Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination​
  Barros-Martins, J.; Hammerschmidt, S. I.; Cossmann, A.; Odak, I.; Stankov, M. V.; Morillas Ramos, G. & Dopfer-Jablonka, A. et al.​ (2021) 
  Nature Medicine,.​ DOI: https://doi.org/10.1038/s41591-021-01449-9 
  ​Details  DOI 

• 2021 | Journal Article | 
  ​ ​Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination​
  Hammerschmidt, S. I.; Bosnjak, B.; Bernhardt, G.; Friedrichsen, M.; Ravens, I.; Dopfer-Jablonka, A. & Hoffmann, M. et al.​ (2021) 
  Cellular & Molecular Immunology, 18(10) pp. 2455​-2456​.​ DOI: https://doi.org/10.1038/s41423-021-00755-z 
  ​Details  DOI 

• 2021 | Journal Article | 
  ​ ​Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance​
  Arora, P.; Kempf, A.; Nehlmeier, I.; Graichen, L.; Sidarovich, A.; Winkler, M. S. & Schulz, S. et al.​ (2021) 
  Cellular & Molecular Immunology, 18(11) pp. 2557​-2559​.​ DOI: https://doi.org/10.1038/s41423-021-00772-y 
  ​Details  DOI 

• 2021 | Journal Article | 
  ​ ​The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency​
  Arora, P.; Rocha, C.; Kempf, A.; Nehlmeier, I.; Graichen, L.; Winkler, M. S. & Lier, M. et al.​ (2021) 
  Cellular & Molecular Immunology, 18(12) pp. 2673​-2675​.​ DOI: https://doi.org/10.1038/s41423-021-00779-5 
  ​Details  DOI 

• 2022 | Journal Article | 
  ​ ​Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2​
  Arora, P.; Kempf, A.; Nehlmeier, I.; Graichen, L.; Schulz, S.; Cossmann, A. & Dopfer-Jablonka, A. et al.​ (2022) 
  Cellular & Molecular Immunology,.​ DOI: https://doi.org/10.1038/s41423-022-00870-5 
  ​Details  DOI 

• 2022 | Journal Article | 
  ​ ​BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19​
  Behrens, G. M. N.; Barros-Martins, J.; Cossmann, A.; Ramos, G. M.; Stankov, M. V.; Odak, I. & Dopfer-Jablonka, A. et al.​ (2022) 
  Nature Communications, 13(1).​ DOI: https://doi.org/10.1038/s41467-022-32527-2 
  ​Details  DOI 

• 2022 | Journal Article | Research Paper | 
  ​ ​Immunogenicity of COVID-19 vaccination in melanoma patients under immune checkpoint blockade​
  Niewolik, J.; Mikuteit, M.; Cossmann, A.; Vahldiek, K.; Gutzmer, R.; Müller, F.   & Schröder, D.  et al.​ (2022) 
  Oncology,.​ DOI: https://doi.org/10.1159/000524894 
  ​Details  DOI 

• 2022 | Journal Article | Research Paper
  ​ ​SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study​
  Dopfer-Jablonka, A.; Steffens, S.; Müller, F. ; Mikuteit, M.; Niewolik, J.; Cossmann, A. & Stankov, M. V. et al.​ (2022) 
  BMC Infectious Diseases, 22(1) art. 403​.​ DOI: https://doi.org/10.1186/s12879-022-07347-w 
  ​Details  DOI  PMID  PMC 

• 2022 | Journal Article | 
  ​ ​Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1​
  Sidarovich, A.; Krüger, N.; Rocha, C.; Graichen, L.; Kempf, A.; Nehlmeier, I. & Lier, M. et al.​ (2022) 
  Viruses, 14(11) art. 2475​.​ DOI: https://doi.org/10.3390/v14112475 
  ​Details  DOI  PMID  PMC 

• 2022 | Journal Article | 
  ​ ​The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant​
  Arora, P.; Zhang, L.; Rocha, C.; Graichen, L.; Nehlmeier, I.; Kempf, A. & Cossmann, A. et al.​ (2022) 
  International Journal of Molecular Sciences, 23(22) pp. 14057​.​ DOI: https://doi.org/10.3390/ijms232214057 
  ​Details  DOI 

• 2023 | Journal Article | 
  ​ ​Migrant healthcare workers during COVID-19: bringing an intersectional health system-related approach into pandemic protection. A German case study​
  Kuhlmann, E.; Ungureanu, M.-I.; Behrens, G. M. N.; Cossmann, A.; Fehr, L. M.; Klawitter, S. & Mikuteit, M. et al.​ (2023) 
  Frontiers in Public Health, 11.​ DOI: https://doi.org/10.3389/fpubh.2023.1152862 
  ​Details  DOI 

• 2023 | Journal Article | 
  ​ ​Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5​
  Hoffmann, M.; Arora, P.; Nehlmeier, I.; Kempf, A.; Cossmann, A.; Schulz, S. R. & Morillas Ramos, G. et al.​ (2023) 
  Cellular & Molecular Immunology, 20(4) pp. 419​-422​.​ DOI: https://doi.org/10.1038/s41423-023-00988-0 
  ​Details  DOI  PMID  PMC 

• 2023 | Journal Article | 
  ​ ​Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage​
  Nehlmeier, I.; Kempf, A.; Arora, P.; Cossmann, A.; Dopfer-Jablonka, A.; Stankov, M. V. & Schulz, S. R. et al.​ (2023) 
  Cellular & Molecular Immunology, pp. 1​-3​.​ DOI: https://doi.org/10.1038/s41423-023-01030-z 
  ​Details  DOI  PMID  PMC 

Researcher

Sort

Items per Page